Inhibrx Biosciences (INBX)'s 30-day implied volatility (IV30) was 72.0% at the close on November 13, 2026, down from 80.5% the day before, against a 52-week range of 58.5% to 159.0%. Its 20-day historical volatility was 91.6%.
Data as of November 13, 2026.